BPS 2015 Proceedings

Boulder Peptide Symposium, 2015

Showcase

Brief 15 minute presentations from companies developing peptide therapeutics and related technologies. This rapid and compressed format is designed for quick introduction between symposium participants to new technologies, and companies. Each presentation is structured to highlight the value of the technology or therapeutic being offered and the business strategy.

Heidi Wilson

Assistant Professor
Claudin Technologies and University of Colorado Denver -Anschutz Medical Campus

A Claudin-Targeting Peptide As a Potential Therapeutic for Ovarian Cancer

Debbie Eckert

Scientific Director, D-Peptide Research Division
Navigen, Inc.

Targeting a Vulnerable Intermediate of Viral Entry with D-Peptide Drugs

Maja Kohn

Principal Investigator
European Molecular Biology Laboratory

Selective peptidic activators for protein phosphatase-1

Michael Sekar

Sr. Director, Formulation Research
Durect Corporation

Organic Solvent-free Subcutaneous Aqueous Depot for GLP-1 Peptide Delivery

Ken Cundy

Chief Scientific Officer
CohBar, Inc.

Developing Mitochondria-Based Therapeutics for Age-Related Diseases

Robin Carmichael

President & COO
Helix BioMedix, Inc

Strategic Pipeline Diversification

M. Karen Newell-Rogers

Professor/Consultant
VG Life Sciences/Texas A&M Health Sciences Center

Targeted Peptide Therapy as a Novel Therapy for Chronic Inflammatory Disease

Richard Hopkins

Director
Phylogica

Phylomer derived cell penetrating peptides facilitate more efficient delivery of peptides and proteins to the cytoplasm

Kenneth Gruber

President/Chief Scientific Officer
Tensive Controls, Inc.

A Platform Technology for Drug-Like Peptides

Peptides In the Clinic

Updates on clinical development of peptide therapeutics.

Jerome Connor

Vice President of Research and Development
Cerapedics Inc

Clinical efficacy of a novel P-15 peptide in anterior cervical arthrodesis: A prospective, randomized, controlled, multicenter study

Deborah O’Neil

Chief Executive & Scientific Officer
NovaBiotics Ltd

First in class anti-infectives from a novel cationic peptide platform

Warren Joseph

Consultant, Lower Extremity Infectious Diseasess
Roxborough Memorial Hospital, Philadelphia, PA

The Clinical Development of Pexiganan for the Treatment of Diabetic Foot Infections

Elizabeth Mittendorf

Associate Professor, Deputy Chair Research, Department of Surgical Oncology
The University of Texas MD Anderson Cancer Center

Injecting Hope: Clinical Development of the NeuVax Vaccine

Jamal Temsamani

Director of Drug Development
Vect Horus

Development of a vectorised neurotensin for therapeutic hypothermia

Drug Delivery

Novel approaches to peptide drug delivery including devices, molecular engineering, conjugation, and formulation technologies

Bobby Singh

CTO
Corium International, Inc.

MICROCORÂ®: A novel platform transdermal technology for convenient and effective delivery of peptides

Bruce Littman

CEO
Portage Pharmaceuticals LTD

Development of a Topical Cell Penetrating Peptide Therapeutic for Inflammatory Eye Diseases

Jim Ballance

VP Research & Scientific Affairs
PhaseBio Pharmaceuticals, Inc.

ELP Biopolymers Significantly Enhance the Pharmacology of Therapeutic Peptides

Daniel Santi

President
ProLynx

A Chemical Approach to Half-life Extension of Peptides and Proteins

Francesca Milletti

Principal Scientist
Roche

Cell-penetrating peptides: current landscape & future applications

Oral Presentations in Scientific Sessions

The session topics for Scientific Program are Peptides in the Clinic, Drug Delivery, Chemistry of Complex Peptides, Spotlight on Discovery, and Peptide Showcase. Abstracts may be submitted via the Apply to Present page on the website. Submissions will be reviewed by the Scientific Advisory Board on a monthly basis and the speaker will be notified of a decision.

Presentation length: Format is 25-30 minutes slide presentation with 5-10 minutes for Q&A, with the exception of Peptide Showcase talks which are 10 minute slide presentations with 5 minutes for Q&A. Please confirm with your session chair to confirm the exact presentation length.

Invited Speakers: Speakers are requested to supply their presentation details 30 days after receiving an invitation to present.

Program Book Deadline: Final abstract and title must be provided no later than September 1st. No changes to the program are possible after this date.

Presentation Format: Oral presenters please provide your presentation slides to the A/V table on the day of your presentation.

Lodging: All speakers are requested to reserve their own room. Discount rates at the conference hotel are available until August 16th.

Registration: All speakers, excluding sponsored presentation speakers, receive a complimentary registration upon approval of the abstract.

Peptide Showcase Description

The Peptide Showcase is an opportunity for an individual or company to “showcase” new ideas, technology and pipeline assets. Priority shall be given to presentations from biotech and startup companies. Service providers and vendors are not eligible. Speakers in the session receive a complimentary event registration.

Posters

Posters can be presented on any topic relevant to peptides including original research, innovative products and technologies.

Eligibility- Any attendee (from academia, industry, biotech or vendor/sponsor) can present a poster. The presentation must contain original scientific thinking. To submit a poster go to the Submit a Poster link from the meeting menu. All submissions are reviewed on a rolling basis and will be notified of approval. September 1st is the last day to submit a poster abstract. Approved posters are published on the BPF website.

A 30 ” x 40″ board shall be provided with thumb tacks. Board will be on an easel and can be rotated for either landscape or portrait formats. Once you apply for a poster, you will get email confirmation that your poster was accepted. The poster session and number assignments will be emailed one week before the Symposium.

Poster boards shall be available for display from 8am to 8pm the day of your assigned poster session. See the program agenda for the poster session schedule.

Public Release

Every presentation at the Boulder Peptide Symposium is automatically recorded. Speakers are required to give consent for sharing of the presentation video with the peptide community.